These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2881967)

  • 1. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene.
    Wilson JG; Wong WW; Murphy EE; Schur PH; Fearon DT
    J Immunol; 1987 Apr; 138(8):2708-10. PubMed ID: 2881967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus.
    Holme E; Fyfe A; Zoma A; Veitch J; Hunter J; Whaley K
    Clin Exp Immunol; 1986 Jan; 63(1):41-8. PubMed ID: 2937582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CR1 polymorphism in hydralazine-induced systemic lupus erythematosus: DNA restriction fragment length polymorphism.
    Mitchell JA; Sim RB; Sim E
    Clin Exp Immunol; 1989 Dec; 78(3):354-8. PubMed ID: 2575471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
    Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
    J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms.
    Moldenhauer F; Botto M; Walport MJ
    Clin Exp Immunol; 1988 Apr; 72(1):74-8. PubMed ID: 2899464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited.
    Walport MJ; Ross GD; Mackworth-Young C; Watson JV; Hogg N; Lachmann PJ
    Clin Exp Immunol; 1985 Mar; 59(3):547-54. PubMed ID: 3987091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association between genetic polymorphism of erythrocyte CR1 and the susceptibility of idiopathic pulmonary fibrosis].
    Yuan YD; Zhao MX; Yu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Nov; 34(11):841-5. PubMed ID: 22333472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus.
    Wilson JG; Jack RM; Wong WW; Schur PH; Fearon DT
    J Clin Invest; 1985 Jul; 76(1):182-90. PubMed ID: 4019777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
    Arora V; Verma J; Dutta R; Marwah V; Kumar A; Das N
    Mol Immunol; 2004 Jun; 41(4):449-56. PubMed ID: 15163541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
    J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CR1 density polymorphism and expression on erythrocytes of patients with systemic lupus erythematosus.
    Kiss E; Csipö I; Cohen JH; Reveil B; Kávai M; Szegedi G
    Autoimmunity; 1996; 25(1):53-8. PubMed ID: 9161700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus.
    Moldenhauer F; David J; Fielder AH; Lachmann PJ; Walport MJ
    Arthritis Rheum; 1987 Sep; 30(9):961-6. PubMed ID: 2959289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of the HindIII restriction fragment length polymorphism among patients with systemic lupus erythematosus with different concentrations of CR1.
    Satoh H; Yokota E; Tokiyama K; Kawaguchi T; Niho Y
    Ann Rheum Dis; 1991 Nov; 50(11):765-8. PubMed ID: 1685310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C3b receptor (CR1) on phagocytic cells from SLE patients: analysis of the defect and familial study.
    Mir A; Porteu F; Levy M; Lesavre P; Halbwachs-Mecarelli L
    Clin Exp Immunol; 1988 Sep; 73(3):461-6. PubMed ID: 2974768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patients with HIV infection.
    Jouvin MH; Rozenbaum W; Russo R; Kazatchkine MD
    AIDS; 1987 Jul; 1(2):89-94. PubMed ID: 2966632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus.
    Wilson JG; Wong WW; Schur PH; Fearon DT
    N Engl J Med; 1982 Oct; 307(16):981-6. PubMed ID: 7110302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma.
    Yoon SH; Fearon DT
    J Immunol; 1985 May; 134(5):3332-8. PubMed ID: 3156931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon.
    Kumar A; Kumar A; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
    Immunol Cell Biol; 1995 Oct; 73(5):457-62. PubMed ID: 8595925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
    Roberts WN; Wilson JG; Wong W; Jenkins DE; Fearon DT; Austen KF; Nicholson-Weller A
    J Immunol; 1985 Jan; 134(1):512-7. PubMed ID: 2578050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.